MoneyWorks4Me

Smruthi Organics - Quaterly Results

12 Nov 2025 Evaluate
A fair growth of 7.50% in the revenue at Rs. 315.95 millions was reported in the September 2025 quarter as compared to Rs. 293.91 millions during year-ago period.The Net Profit of the company vaulted to 165.42% to Rs. 20.57  millions from Rs. 7.75 millions in the previous quarter.Operating profit for the quarter ended September 2025 rose to 50.21 millions as compared to 29.02 millions of corresponding quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 315.95 293.91 7.50 505.87 566.64 -10.72 1260.08 1276.43 -1.28
Other Income 0.10 0.07 42.86 0.98 0.09 988.89 0.89 0.76 17.11
PBIDT 50.21 29.02 73.02 53.38 33.50 59.34 122.71 120.31 1.99
Interest 6.60 4.38 50.68 11.22 8.46 32.62 18.70 14.08 32.81
PBDT 43.61 24.64 76.99 42.16 25.04 68.37 104.01 106.23 -2.09
Depreciation 15.14 13.33 13.58 29.22 26.27 11.23 55.01 56.53 -2.69
PBT 28.47 11.31 151.72 12.94 -1.23 -1152.03 49.00 49.70 -1.41
TAX 7.90 3.56 121.91 3.32 0.24 1283.33 13.37 13.79 -3.05
Deferred Tax 2.65 2.40 10.42 -1.88 -0.92 104.35 -0.32 -2.27 -85.90
PAT 20.57 7.75 165.42 9.62 -1.47 -754.42 35.63 35.91 -0.78
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 15.89 9.87 60.95 10.55 5.91 78.49 9.74 9.43 3.32
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..